- Home
- HLN vs LVS Comparison
HLN vs LVS Comparison
Compare HLN & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLN
- LVS
- Stock Information
- Founded
- HLN 2022
- LVS 1988
- Country
- HLN United Kingdom
- LVS United States
- Employees
- HLN N/A
- LVS N/A
- Industry
- HLN Package Goods/Cosmetics
- LVS Hotels/Resorts
- Sector
- HLN Consumer Discretionary
- LVS Consumer Discretionary
- Exchange
- HLN Nasdaq
- LVS Nasdaq
- Market Cap
- HLN 48.2B
- LVS 34.2B
- IPO Year
- HLN N/A
- LVS 2004
- Fundamental
- Price
- HLN $9.96
- LVS $49.97
- Analyst Decision
- HLN Buy
- LVS Buy
- Analyst Count
- HLN 1
- LVS 14
- Target Price
- HLN $10.95
- LVS $55.62
- AVG Volume (30 Days)
- HLN 13.5M
- LVS 4.8M
- Earning Date
- HLN 07-31-2025
- LVS 07-23-2025
- Dividend Yield
- HLN 1.78%
- LVS 1.98%
- EPS Growth
- HLN 38.94
- LVS N/A
- EPS
- HLN 0.20
- LVS 1.78
- Revenue
- HLN $14,062,871,660.00
- LVS $11,201,000,000.00
- Revenue This Year
- HLN $3.63
- LVS $5.22
- Revenue Next Year
- HLN $4.37
- LVS $5.86
- P/E Ratio
- HLN $24.68
- LVS $27.92
- Revenue Growth
- HLN N/A
- LVS N/A
- 52 Week Low
- HLN $8.68
- LVS $30.18
- 52 Week High
- HLN $11.42
- LVS $56.61
- Technical
- Relative Strength Index (RSI)
- HLN 26.82
- LVS 74.79
- Support Level
- HLN $10.01
- LVS $47.47
- Resistance Level
- HLN $10.15
- LVS $50.67
- Average True Range (ATR)
- HLN 0.11
- LVS 1.04
- MACD
- HLN -0.04
- LVS 0.54
- Stochastic Oscillator
- HLN 3.68
- LVS 92.29
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.